Literature DB >> 19412672

Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin.

Guo-Qing Chen1, Zhi-Wei Zhao, Hong-Ying Zhou, Yuan-Jie Liu, Hui-Jun Yang.   

Abstract

Multidrug resistance remains a major clinical obstacle to successful treatment of breast cancer and leads to poor prognosis for the patients. Recently studies have shown that microRNAs play an important role in breast cancer cell resistance to chemotherapeutic agents. In this study, microRNA expression profiles of MCF-7/AdrVp and MCF-7 were analyzed using microarray and the results were confirmed by real-time RT-polymerase chain reaction. Gene Ontology (GO) and pathways mapping tools were employed to analyse systemically the biological processes and signaling pathways affected by differential expression microRNAs. Here, we showed that 181 human microRNAs were differentially expressed between two cell lines. Compared to MCF-7 cells, there were 16 microRNAs down-regulated and 165 microRNAs up-regulated in MCF-7/AdrVp. Western blot confirmed the correlation between specific microRNA expression and corresponding changes in protein levels of their targets, specifically those that have a documented role in cancer drug resistance. Furthermore, we validated that signaling pathway highlighted in the study was involved in drug resistance. These results indicated that breast cancer cell resistant to chemotherapy was associated with a group of microRNAs. GO and pathway mapping are valid and effective approach to analyse the function of microRNAs and the results could be a guideline for further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412672     DOI: 10.1007/s12032-009-9225-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells.

Authors:  Rita Nahta; Linda X H Yuan; Bing Zhang; Ryuji Kobayashi; Francisco J Esteva
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

Review 5.  Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA.

Authors:  Yuriy Gusev
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

6.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

Review 7.  Her2 cross talk and therapeutic resistance in breast cancer.

Authors:  Laura M Bender; Rita Nahta
Journal:  Front Biosci       Date:  2008-05-01

8.  MicroRNAs modulate the chemosensitivity of tumor cells.

Authors:  Paul E Blower; Ji-Hyun Chung; Joseph S Verducci; Shili Lin; Jong-Kook Park; Zunyan Dai; Chang-Gong Liu; Thomas D Schmittgen; William C Reinhold; Carlo M Croce; John N Weinstein; Wolfgang Sadee
Journal:  Mol Cancer Ther       Date:  2008-01-09       Impact factor: 6.261

9.  Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.

Authors:  Shingo Takagi; Miki Nakajima; Takuya Mohri; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

10.  miRGator: an integrated system for functional annotation of microRNAs.

Authors:  Seungyoon Nam; Bumjin Kim; Seokmin Shin; Sanghyuk Lee
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

View more
  34 in total

Review 1.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

2.  MicroRNA profiles of drug-resistant myeloma cell lines.

Authors:  Reinhold Munker; Chang-Gong Liu; Cristian Taccioli; Hansjuerg Alder; Nyla Heerema
Journal:  Acta Haematol       Date:  2010-03-31       Impact factor: 2.195

3.  Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis [corrected].

Authors:  Chiranjib Chakraborty; C George Priya Doss; Renu Sarin; Minna J Hsu; Govindasamy Agoramoorthy
Journal:  Protoplasma       Date:  2015-02-20       Impact factor: 3.356

4.  Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.

Authors:  Benjamin Boyerinas; Sun-Mi Park; Andrea E Murmann; Katja Gwin; Anton G Montag; Marion Zillhardt; You-Jia Hua; Ernst Lengyel; Marcus E Peter
Journal:  Int J Cancer       Date:  2011-08-16       Impact factor: 7.396

Review 5.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

6.  Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.

Authors:  Elham Tafsiri; Mojtaba Darbouy; Mohammad B Shadmehr; Anna Zagryazhskaya; Javad Alizadeh; Morteza Karimipoor
Journal:  Tumour Biol       Date:  2014-11-11

7.  miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Authors:  Wei Zhu; DanXia Zhu; Shiqiang Lu; Tongshan Wang; Jian Wang; Binghua Jiang; Yongqian Shu; Ping Liu
Journal:  Med Oncol       Date:  2011-01-22       Impact factor: 3.064

8.  A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p.

Authors:  Rania El Majzoub; Mohammad Fayyad-Kazan; Assaad Nasr El Dine; Rawan Makki; Eva Hamade; René Grée; Ali Hachem; Rabih Talhouk; Hussein Fayyad-Kazan; Bassam Badran
Journal:  Genes Genomics       Date:  2019-09-20       Impact factor: 1.839

9.  MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.

Authors:  Mithu Raychaudhuri; Holger Bronger; Theresa Buchner; Marion Kiechle; Wilko Weichert; Stefanie Avril
Journal:  Breast Cancer Res Treat       Date:  2017-02-08       Impact factor: 4.872

Review 10.  MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications.

Authors:  Wei Tian; Junqing Chen; Haifei He; Yongchuan Deng
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.